20 Participants NeededMy employer runs this trial

Vagustim Device for Healthy Controls

SV
CS
Overseen ByChristine Sethna, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwell Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Transcutaneous auricular vagus nerve stimulation (taVNS) has become a therapy of interest for treating chronic immune-medicated illnesses in adults and children. Vagustim™ taVNS devices are commercially available devices that have been used in clinical and non-clinical studies examining inflammatory conditions. Previous work of the investigative team has utilized TENS devices from Roscoe Medical to deliver stimulation. We aim to evaluate Vagustim™'s sham stimulation method as a placebo for clinical trials.

Are You a Good Fit for This Trial?

This trial is for healthy adults aged 18 or older who can give consent and are willing to follow study procedures. People with heart problems, chronic inflammatory or kidney diseases, certain ear skin issues, implanted electronic devices, or those who are pregnant or breastfeeding cannot participate.

Inclusion Criteria

I am willing and able to follow all study procedures for the entire study period.
I am 18 years old or older.
I am able to give consent or have someone who can consent for me.

Exclusion Criteria

I have a history of heart problems or irregular heartbeat.
Participants or guardians who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures
I have a chronic inflammatory or kidney condition, not just a temporary urinary issue.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive a one-time 10-minute taVNS or sham treatment with blood samples taken pre-treatment and 2 hours post-treatment

1 day
1 visit (in-person)

Follow-up

Participants are monitored for cytokine levels post-treatment to evaluate the feasibility of the sham methodology

2 hours

What Are the Treatments Tested in This Trial?

Interventions

  • Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Device

Trial Overview

The study is testing the Vagustim™ device that stimulates the vagus nerve through the ear. It aims to evaluate how well its sham (placebo) stimulation works in comparison to real stimulation among healthy volunteers.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: Active treatmentActive Control1 Intervention
Group II: Sham treatmentPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwell Health

Lead Sponsor

Trials
481
Recruited
470,000+